Sociedad Americana de Hirudoterapia

Marco regulatorio

Comprensión de la base legal y regulatoria de la hirudoterapia en los Estados Unidos

Last Updated: March 1, 2026Reviewed by: Andrei Dokukin, MDRegulatory Status: FDA-Cleared (Tier 1)

FDA-Cleared Indication

This page presents factual regulatory information regarding the FDA 510(k) clearance status of medicinal leeches in the United States.

Las sanguijuelas medicinales ocupan una posición regulatoria única: son dispositivos médicos vivos autorizados por la FDA bajo 510(k). Comprender este marco es esencial para la práctica legal, el consentimiento informado, la codificación de seguros y el desarrollo de políticas institucionales.

Historial de autorizaciones FDA 510(k)

510(k) NumberYearApplicantSpeciesIndication
K0401872004Ricarimpex SAS (France)Hirudo medicinalis, H. verbanaVenous congestion relief in flaps/replants
K1329582014Biopharm UK LtdHirudo verbanaSame as K040187
K1409072015Carolina Biological Supply Co.Hirudo verbanaSame as K040187

Cleared Indications (Exact FDA Language)

  1. Pooling of blood beneath tissue grafts where there is no other mechanism of adequate venous drainage
  2. Restoring blood circulation in blocked veins by removing pooled blood

Product classification: Leech, Medicinal. Product code: NRN. 510(k)-cleared medical device.

Cronología del recorrido regulatorio

Pre-2004

Medicinal leeches used in hospitals under physician discretion without FDA oversight

2004

FDA grants first 510(k) clearance (K040187) to Ricarimpex SAS under CDRH

2014-2015

Two additional 510(k) clearances granted (K132958, K140907)

Dec 2024

Regulatory responsibility transferred from CDRH to CBER (Federal Register 2024-31266)

Clasificación y requisitos

Device Classification

  • Class: Pre-Amendment (510(k) Required)
  • Product code: NRN
  • Center: CBER (since Dec 30, 2024; previously CDRH)
  • Single-use: Required — leeches cannot be reused between patients

Supplier Requirements

  • 510(k) clearance for each supplier
  • Species identification (H. medicinalis or H. verbana)
  • QMSR compliance (21 CFR Part 820, ISO 13485:2016)
  • Batch traceability and lot documentation

Single-Use Requirement

Medicinal leeches are single-use medical devices. Post-procedure euthanasia is performed by immersion in 70% ethanol. Reuse between patients violates FDA clearance conditions.

Consideraciones de alcance de práctica por estado

Who May Apply Medicinal Leeches?

Scope-of-practice authority varies by state. Common scenarios:

  • Physicians (MD/DO): Authorized in all states
  • Nurse Practitioners: State-dependent; independent in 26 states + DC
  • Naturopathic Physicians (ND): Varies significantly by state
  • Registered Nurses: Under physician order/standing protocol
  • Acupuncturists/Other: Generally NOT authorized

Legal Disclaimer

Scope-of-practice laws are state-specific and subject to change. Practitioners should verify current requirements with their state licensing board.

Implicaciones de seguros y codificación

Coding Options

  • CPT 17999: Unlisted procedure (most commonly used)
  • HCPCS C1765: Adhesion barrier (hospital outpatient)
  • ICD-10: Code to underlying condition

Coverage Reality

  • Aetna CPB 0556: Covers flap/replant salvage as medically necessary
  • Medicare: No national coverage determination
  • Hospital inpatient: Typically absorbed into DRG payment

Panorama regulatorio internacional

JurisdictionClassificationStatus
United States510(k)-Cleared Medical DeviceFDA-cleared for venous congestion
European UnionMedicinal Product / Medical DeviceCE marked; harmonization ongoing
RussiaApproved medical therapyBroadly approved; pharmacopeial monograph
WHOTraditional medicine (ICD-11)Included in ICD-11 traditional medicine module
IndiaUnani/Traditional medicinePracticed under AYUSH framework

Posición de ASH

The American Society of Hirudotherapy supports the current FDA 510(k) framework and advocates for evidence-based expansion of cleared indications as clinical data matures. ASH recommends that all practitioners verify their state scope-of-practice authority and use only FDA-registered leech suppliers.

Recursos relacionados

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.